Lake Street lowered the firm’s price target on Cardlytics (CDLX) to $3 from $5 and keeps a Hold rating on the shares. The firm believes the stock “remains in the proving grounds,” but adds it is encouraged by emerging better ad delivery performance and supply side inventory. The firm cites broader multiple compression in the space for its price target cut.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDLX: